ITMO public health
Last update : 05/06/2021 | Version : 1 | ID : 73902
| General | |
| Identification | |
| Detailed name | Clinical events occurring within 6 months of SARS-COV-2 infection: multicentre cohort |
| Sign or acronym | COCO_LATE |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL MR01, favorable opinion CPP |
| General Aspects | |
| Medical area |
Infectious diseases Psychology and psychiatry |
| Study in connection with Covid-19 |
Yes |
| Scientific investigator(s) (Contact) | |
| Name of the director | ROBINEAU |
| Surname | Olivier |
| Collaborations | |
| Participation in projects, networks and consortia |
Yes |
| Funding | |
| Funding status |
Public |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | Tourcoing Hospital |
| Organisation status |
Public |
| Presence of scientific or steering committees |
Yes |
| Additional contact | |
| Name of the contact | TREHOUX |
| Surname | Solange |
| recherche@ch-tourcoing.fr | |
| Main features | |
| Type of database | |
| Type of database |
Others |
| Study databases (details) |
Cohort study |
| Database objective | |
| Main objective |
Describe, over time, the symptoms presented by patients reporting persistent symptoms (more than two months after onset) or onset of symptoms more than 3 weeks after the beginning of symptomatic SARS-CoV-2 (COVID-19) infection evidenced by laboratory tests.
|
| Inclusion criteria |
1- History of symptomatic SARS-CoV-2 infection defined by:
A positive RT-PCR result for SARS-CoV-2 OR positive SARS-CoV-2 serology combined with at least one event: - Anosmia occurring after February 2020 - OR CT scan consistent with COVID-19 - OR ? 2 symptoms coinciding with the virology sample, including: asthenia, cough, dyspnoea, fever, myalgia, dysgeusia, diarrhoea AND not present prior to diagnosis 2- AND persistence of at least one symptom present in the first 3 weeks of COVID-19, more than 8 weeks after the first COVID symptoms OR late onset of at least one new symptom at least 3 weeks and not more than 6 months after the first symptoms of SARS-CoV-2 infection 3- First symptoms within the past 6 months on the date of inclusion 4- Beneficiary of a health insurance scheme or the state welfare scheme 5- Having signed an informed consent form at inclusion |
| Population type | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
Sick population |
| Pathology | B99-B99 - Other infectious diseases |
| Gender |
Male Woman |
| Geography area |
National |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2020 |
| Size of the database | |
| Size of the database (number of individuals) |
[500-1000[ individuals |
| Data | |
| Database activity |
Current data collection |
| Type of data collected |
Clinical data Paraclinical data Biological data |
| Clinical data (detail) |
Direct physical measures Medical registration |
| Presence of a biobank |
Yes |
| Contents of biobank |
Serum Plasma |
| Procedures | |
| Followed pathology | |
| Promotion and access | |
| Promotion | |
| Access |
| ABOUT | CATALOG | RESOURCES | USEFUL LINKS |
This site complies with the HONcode standard for trustworthy health information: |
8 rue de la Croix Jarry 75013 Paris Phone : +33 1 44 23 67 47 |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05
